Until 2017, Schneider Electric faced a factory bottleneck at its breaker box plant in Lexington, Kentucky. When the automation cell that welded the boxes went down, all production could be forced to stop.
Robotics Australia Group is asking creators of robotics and robotics-related technology to complete the Australian Government’s new survey of Australia’s artificial intelligence (AI) and autonomous systems capability.
Nikon Metrology today announced a new partnership with NSI Microscopy Inspection Automation of Wexford, Ireland. The agreement will help customers with Continuous Process Improvement by making use of automated microscopy, according to the company.
John Deere’s Eric Johnson discusses the company’s additive manufacturing journey—with an eye toward helping small and medium businesses get going in AM. Learn about the early days of getting one of the first AM parts, as well as unrealistic expectations of the technology and how John Deere is creating value with the technology today. Finally, Johnson provides tips on unlocking the value of AM for your business in five key applications.
According to a survey conducted by ISM, 75 percent of U.S. manufacturing companies experienced delayed resources and materials due to the COVID-19 pandemic. The outbreak has forced manufacturers to rethink supply chains to allow for product diversification.
The Oregon Manufacturing Innovation Center Research and Development (OMIC R&D), a manufacturing research campus hosted by Oregon Tech, has received a $154,000 sponsored project from SMW-AUTOBLOK Corp.
Three partners contributed their diverse manufacturing and machining experience—and their last initials—to found SPR Machine in 2002.
The U.S. Department of Defense (DoD) wants the industry to secure the country’s leadership in hypersonic weaponry. The request is no small feat.
Deloitte and Wichita State University announced the launch of The Smart Factory @ Wichita,
In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.
